In recent years, the demand for high-quality synthetic peptides in North American research facilities has surged significantly. The global peptide therapeutics market is expanding rapidly, making localized supply chains more critical than ever before. As laboratories expand their focus on biotechnology, proteomics, and pharmaceutical development, sourcing cost-effective and highly pure materials becomes a top priority